When is autologous stem cell transplant recommended for multiple myeloma?

Before transplant, medicines are usually used to reduce the myeloma burden, followed by collection and storage of the person’s own blood-forming stem cells. High-dose treatment is then given, and the stored cells are returned to support bone marrow recovery. The specialist considers response to initial therapy, kidney and heart function, frailty, infections, other illnesses, medicines, and the person’s goals. Age alone does not decide eligibility, and a transplant can be discussed even when the diagnosis has been recent.

Bring a complete medicine list and ask how kidney function, bone problems, blood counts, or previous infections affect the plan. The assessment may include blood tests, imaging, heart and lung checks, infection screening, and a review of dental health. Discuss fertility preservation when relevant, time away from work, transport, caregiver help, food and hygiene precautions, and how the team will manage pain or other myeloma symptoms. A second specialist opinion can clarify choices when the decision feels uncertain.

Call the myeloma or transplant team urgently for fever, shaking chills, breathlessness, chest pain, unusual bleeding, severe weakness, confusion, or reduced urine. During preparation, report new infection symptoms, dehydration, worsening bone pain, or medicine reactions before the next treatment. After the cells are returned, even a mild new illness may need rapid assessment because blood counts can be low while the marrow recovers.

What response do you expect before collection? Is transplant recommended now or can it be delayed? How will my kidneys and other conditions change the preparation? Will stem cells be stored for future use? Which home symptoms should trigger an immediate call?